Economy News Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints by December 20, 2024 written by December 20, 2024 Post Content 0 FacebookTwitterPinterestEmail previous post Capital Economics says consumption momentum stalls with flat retail sales next post Fed’s Hammack says economic strength argued against rate cut Related News Singapore Post fires CEO over handling of whistleblower... December 23, 2024 Dollar steady after benign US inflation eases worries... December 23, 2024 Brace! Risks stack up for the global economy... December 23, 2024 Asia shares rally on US inflation relief December 23, 2024 UK business morale falls to 2024 low but... December 23, 2024 Trump names former staffer Katie Miller to Musk-led... December 22, 2024 Oil steady as markets weigh Fed rate cut... December 22, 2024 Singapore Post fires CEO over handling of whistleblower... December 22, 2024 Trump taps ex-Treasury official Miran as chair of... December 22, 2024 Trump taps ex-Treasury official Miran as chair of... December 22, 2024
